Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Pharmaceutical Quality Control Release Testing Service Market Size And Revenue Outlook Through 2030
The pharmaceutical quality control release testing service market has demonstrated strong expansion over recent years. It is projected to increase from a valuation of $7.55 billion in 2025 to $8.13 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. Historically, this market’s growth can be attributed to factors such as more rigorous GMP regulations, an uptick in global drug manufacturing, the proliferation of contract testing laboratories, a rise in biologics testing requirements, and the continued expansion of generic drug production.
The market for pharmaceutical quality control release testing services is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $11.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this projected growth include the expanding pipelines of complex biologics, more frequent regulatory audits, the increasing adoption of outsourced quality control models, a greater need for accelerated batch release cycles, and a rise in multi-regional drug approvals. Key trends expected during this period encompass automated batch release testing, the implementation of digital laboratory quality systems, artificial intelligence (AI)-assisted analytical validation, interconnected stability testing laboratories, and intelligent quality data platforms.
Get A Free Sample Report With In-Depth Market Insights:
Pharmaceutical Quality Control Release Testing Service Market Growth Factors Behind Sustained Expansion
The expansion of cell or gene therapy pipelines is projected to drive the growth of the pharmaceutical quality control release testing service market moving forward. The cell and gene therapy pipeline refers to the genetic and cellular therapeutic products currently under development and regulatory evaluation for commercialization. This expansion is predominantly fueled by increasing investment in biotechnology research and development, as pharmaceutical companies and biotech firms commit substantial resources towards innovative cellular and genetic treatments for conditions that were previously untreatable. The growing cell and gene therapy pipeline directly escalates the demand for specialized quality control release testing services to ensure these intricate biological products meet rigorous safety and efficacy standards before becoming available commercially. For instance, in January 2025, according to the American Society of Gene and Cell Therapy, a US-based scientific association, the global gene therapy pipeline reached 2,117 programs in the fourth quarter of 2024, which was an increase from 2,041 programs in the third quarter of 2024. Therefore, the broadening of cell or gene therapy pipelines is boosting the pharmaceutical quality control release testing service market’s growth.
Pharmaceutical Quality Control Release Testing Service Market Segment Analysis And Revenue Potential
The pharmaceutical quality control release testing service market covered in this report is segmented –
1) By Product Type: Dissolution Testing; Anti-Corrosion Testing; ICH Stability Storage and Testing; Other Product Types
2) By Service Type: Analytical Testing Services; Microbiological Testing Services; Stability Testing Services; Sterility Testing Services
3) By Technology: Gas Chromatography (GC); Mass Spectrometry; Spectroscopy Methods
4) By End Users: Pharmaceutical Manufacturers; Biotechnology Companies; Contract Development and Manufacturing Organizations (CDMOs); Contract Manufacturing Organizations (CMOs); Research and Academic Institutions
Subsegments:
1) By Dissolution Testing: Immediate Release Testing; Extended Release Testing; Delayed Release Testing; Sink Condition Evaluation
2) By Anti-Corrosion Testing: Packaging Material Corrosion Testing; Container Compatibility Assessment; Environmental Stress Corrosion Testing; Protective Coating Evaluation
3) By ICH Stability Storage and Testing: Long Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing
4) By Other Product Types: Impurity Profiling; Residual Solvent Testing; Elemental Impurity Analysis; Container Closure Integrity Testing
Pharmaceutical Quality Control Release Testing Service Market Industry Trends Fueling Future Revenue Growth
Leading companies in the pharmaceutical quality control release testing services market are focusing on developing advanced solutions, such as microbiological quality control testing, to ensure product sterility, regulatory compliance, and timely batch release. Microbiological quality control testing utilizes microbiological techniques to monitor and measure microbial presence in pharmaceutical products and production environments. This process helps confirm sterility, maintain product safety, and meet regulatory requirements before batch release. For instance, in March 2025, Nelson Laboratories, a US-based microbiological testing company, launched its Rapid Sterility Testing, a microbiology-based quality control testing offering designed to modernize sterility assurance processes. This solution supports faster batch release of sterile pharmaceutical products. It shortens traditional fourteen-day incubation timelines to approximately six days and incorporates automated, quantitative data analytics to enhance result precision, reduce manual intervention, and improve overall testing reliability.
Pharmaceutical Quality Control Release Testing Service Market Leading Players And Competitive Positioning
Major companies operating in the pharmaceutical quality control release testing service market are Labcorp Holdings Inc., SGS S.A., Eurofins Scientific SE, Selvita S.A., WuXi AppTec Co. Ltd., Intertek Group plc, Charles River Laboratories International Inc., Piramal Pharma Limited, Siegfried Holding AG, Almac Group Limited, NSF International, ClinChoice Inc., BioAgilytix Inc., Microbac Laboratories Inc., ARL Bio Pharma Inc., Quality Chemical Laboratories LLC, Neopharm Labs Inc., Butterworth Laboratories Limited, Cambridge Polymer Group Inc., Honeyman Group Limited, and Element Materials Technology Group Limited.
View The Full Pharmaceutical Quality Control Release Testing Service Market Report:
Pharmaceutical Quality Control Release Testing Service Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the pharmaceutical quality control release testing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical quality control release testing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
